Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J.
Acta Haematologica Polonica 25(4): 363-368
1994
ISSN/ISBN: 0001-5814 PMID: 7531381 Document Number: 432565
Twenty nine patients (7 women, 22 men) with III and IV stage of Hodgkin's disease were treated according to alternating programme ChLVPP/ABV. The results were evaluated in 27 patients. Complete remission was obtained in 41% (11 patients), partial remission in 22% (6 patients). Applied treatment revealed a relatively small toxicity.
Document emailed within 1 workday
Related Documents
Gobbi, P.G.; Pieresca, C.; Cavanna, L.; Corbella, F.; Vallisa, D.; Federico, M.; Formisano, R.; Carotenuto, M.; Merli, F.; Callea, V.; Angrilli, F.; Silingardi, V. 1996: CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. a prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) Haematologica 81(6): 503-512Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Angrilli, F.; Pennese, E.; Di Marzio, A.; Liberatore, E.; Di Lorenzo, R.; Fioritoni, G. 2002: A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma Haematologica 87(11): 1227-1229
Klimek, A.; Krykowski, E. 1972: Polyneuropathy developing during vinblastine treatment for Hodgkin's disease Neurologia i Neurochirurgia Polska 6(1): 131-133
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Mikami, K.; Nakagawa, S.; Sugimoto, K.; Nomoto, T.; Urano, S.; Watanabe, H.; Iwamoto, N.; Yamazaki, S.; Hiratake, Y.; Maegawa, M. 1997: Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria Hinyokika Kiyo. Acta Urologica Japonica 43(8): 561-566
Raina, V.; Sharma, A.; Mohanti, B.K.; Kumar, R.; Dawar, R.; Rath, G.K. 2003: Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease National Medical Journal of India 16(4): 199-203
Hainsworth, J.D.; Burnett, L.S.; Jones, H.W.; Greco, F.A. 1983: Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP) Cancer Treatment Reports 67(4): 393-395
Sörenson, S.; Hansen, H.H.; Dombernowsky, P. 1976: Phase Ii study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung Cancer Treatment Reports 60(9): 1263-1266
Ramsay, N.K.; Coccia, P.F.; Krivit, W.; Bloomfield, C.D.; Nesbit, M.E. 1976: Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia Cancer Treatment Reports 60(11): 1683-1685
Escobar, H.; Suárez, L. 1976: Histiocytosis X. Three cases treated with prednisone and vinblastine Anales Espanoles de Pediatria 9(4 Suppl): 100-103
Diehl, L.F.; Perry, D.J.; Terebelo, H.; Baldwin, P.E.; Hurwitz, M.; Kimball, D.B.; Dorn, R.V. 1983: Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy Cancer Treatment Reports 67(9): 827-829
Paty, J.G.; Ruffner, B.W. 1980: Bleomycin-vinblastine associated Raynaud's phenomenon Journal of Rheumatology 7(6): 927-928
Bezwoda, W.R.; MacDonald, D.F.; Gear, J.S.; Derman, D.P.; Bothwell, T.H.; Sqi, S.; Hurwitz, S.; Lewis, D. 1978: Combination chemotherapy including bleomycin in the treatment of advanced Hodgkin's disease South African Medical Journal 53(10): 369-373
Knost, J.A.; Oldham, R.K.; Hande, K.R.; Rhamy, R.K.; Greco, F.A. 1981: Combination of vinblastine and bleomycin in metastatic renal cell carcinoma Cancer Treatment Reports 65(3-4): 349-350
Cheung, W.K.; Aiache, M.; Yacobi, A.; Silber, B.M. 1988: Changes in tissue concentrations of 14C-doxorubicin caused by mitoxantrone, mithramycin A and vinblastine in the rat Research Communications in Chemical Pathology and Pharmacology 59(1): 61-68
Cantwell, B.M.; Harris, A.L.; Patrick, D.; Hall, R.R. 1986: Hemorrhagic cystitis after I.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer Cancer Treatment Reports 70(4): 548-549
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Einhorn, L.H.; Williams, S.D. 1978: Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin Cancer Treatment Reports 62(9): 1351-1353
Jaksić, B.; Brugiatelli, M. 1988: High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCi CLL-01 trial Nouvelle Revue Francaise d'Hematologie 30(5-6): 437-442